Related Experiment Video

Updated: Nov 6, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.4K

Identifying small-cell lung cancer subtypes and potential therapeutic targets

Rose McNulty

    The American Journal of Managed Care
    |May 5, 2021
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    10.8K
    Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
    08:52

    Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

    Published on: November 22, 2021

    4.3K

    Related Experiment Videos

    Last Updated: Nov 6, 2025

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.4K
    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    10.8K
    Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
    08:52

    Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

    Published on: November 22, 2021

    4.3K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    8.0K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    8.0K

    Articles linked to this work by shared authors, journal, and citation graph.

    Multidisciplinary Approach to Familial Pulmonary Fibrosis.

    Radiographics : a review publication of the Radiological Society of North America, Inc·2025

    ACCC and ASCO collaborative targets disparities in cancer clinical trials.

    The American journal of managed care·2021

    Kavita Patel: drug pricing, care access priorities in federal health care policy.

    The American journal of managed care·2021

    Prescription drug prior authorization: costs to pharmacies and physicians.

    The American journal of managed care·2026

    Combined pharmacotherapy and psychotherapy impact on opioid use disorder treatment.

    The American journal of managed care·2026

    The societal costs of food insecurity: implications for managed care strategies.

    The American journal of managed care·2026

    Availability of hospital financial assistance documents in non-English languages.

    The American journal of managed care·2026

    Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

    The American journal of managed care·2026

    Social needs screening and supplemental benefits in Medicare Advantage.

    The American journal of managed care·2026

    Detecting drug-induced nephrotoxicity using simultaneous label-free autofluorescence multiharmonic microscopy.

    Toxicological sciences : an official journal of the Society of Toxicology·2026

    Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.

    The oncologist·2026

    AK050834 Deficiency Prevents Vascular Aging via Opposite Regulation of Two Senescence-Sensitive Genes ATF3 and p21.

    Aging cell·2026

    Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Immunotherapy of malignant melanoma using T cell-activating microbeads.

    Journal of immunology (Baltimore, Md. : 1950)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us